Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Harvard Business School
Moodys
Merck
Colorcon

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for SCHERING CORPORATION v. SANDOZ INC. (D.N.J. 2008)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

SCHERING CORPORATION v. SANDOZ INC. (D.N.J. 2008)

Docket   Start Trial Date Filed 2008-04-03
Court District Court, D. New Jersey Date Terminated 2008-07-16
Cause 35:145 Patent Infringement Assigned To Mary Little Cooper
Jury Demand None Referred To John J. Hughes
Parties SANDOZ INC.; SCHERING CORPORATION
Patents 4,282,233; 4,371,516; 4,552,899; 4,659,716; 4,804,666; 4,863,931; 5,314,697; 5,595,997; 6,100,274; 6,132,758; 6,514,520; 6,979,463
Attorneys ERIC I. ABRAHAM; RICHARD HERNANDEZ; WILLIAM J. O'SHAUGHNESSY
Firms Eric I. Abraham; McCarter & English, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in SCHERING CORPORATION v. SANDOZ INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for SCHERING CORPORATION v. SANDOZ INC. (D.N.J. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-04-03 1 States Patent No. 6,100,274 ("the '274 patent"). This action is based upon the Patent Laws… The Patent 6. On August 8, 2000, the '274 patent, titled "8-…recover for any infringement of that patent. A copy of the '274 patent is attached hereto as Exhibit A.…regarding the '274 patent, constitutes infringement of the '274 patent under 35 U.S.C. § 271(…infringement of the '274 patent, prior to the expiration of the '274 patent, including any extensions External link to document
2008-08-06 10 . 424/250 4,008,795 A 2/1977 Aylon .. 198/460 4,282,233 A 8/1981 Vilani .. 424/267 4,371,516 A 2/1983 …Schering filed patent information with the FDA for both the ‘274 patent and the ‘463 patent, causing the…for infringement of United States Patent No. 6,100,274 (“the ‘274 patent”) under 35 U.S.C. § 27l(e)(2)(A…States Patent No. 6,979,463. FIRST COUN'I`ERCLAIM (DECLARATION OF NONINFRINGEMENT OF U.S. PATENT NO.…SandoZ with infringement of U.S. Patent No. 6,100,274 (“the ‘274 patent”) based upon Sandoz’s filing with External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson
Dow
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.